Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolarix in advanced hepatocellular carcinoma
NCT00746590Phase 2Terminated
- Sponsor
- Bio-Technology General
- Start
- Sep 2008
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of caricotamide in hepatocellular carcinoma (HCC), sponsored by Bio-Technology General. Started Sep 2008; status: terminated.
02
Drugs
caricotamide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00746590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00746590.